☰

Joel D. Schilling, Ph.D. - Publications

Affiliations: 
2003 Washington University, Saint Louis, St. Louis, MO 
Area:
Immunology, Microbiology Biology, Pathology
Tree Info Similar researchers PubMed Report error

31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Chandra P, He L, Zimmerman M, Yang G, Köster S, Ouimet M, Wang H, Moore KJ, Dartois V, Schilling JD, Philips JA. Inhibition of Fatty Acid Oxidation Promotes Macrophage Control of Mycobacterium tuberculosis. Mbio. 11. PMID 32636249 DOI: 10.1128/Mbio.01139-20  0.354
2019 Javaheri A, Bajpai G, Picataggi A, Mani S, Foroughi L, Evie H, Kovacs A, Weinheimer CJ, Hyrc K, Xiao Q, Ballabio A, Lee JM, Matkovich SJ, Razani B, Schilling JD, et al. TFEB activation in macrophages attenuates postmyocardial infarction ventricular dysfunction independently of ATG5-mediated autophagy. Jci Insight. 4. PMID 31672943 DOI: 10.1172/Jci.Insight.127312  0.334
2019 Kalugotla G, He L, Weber KJ, Daemen S, Reller A, Razani B, Schilling JD. Frontline Science: Acyl-CoA synthetase 1 exacerbates lipotoxic inflammasome activation in primary macrophages. Journal of Leukocyte Biology. PMID 31166619 DOI: 10.1002/Jlb.3Hi0219-045Rr  0.301
2018 Weber KJ, Sauer M, He L, Tycksen E, Kalugotla G, Razani B, Schilling JD. PPARγ Deficiency Suppresses the Release of IL-1β and IL-1α in Macrophages via a Type 1 IFN-Dependent Mechanism. Journal of Immunology (Baltimore, Md. : 1950). PMID 30143592 DOI: 10.4049/Jimmunol.1800224  0.308
2017 Sergin I, Evans TD, Zhang X, Bhattacharya S, Stokes CJ, Song E, Ali S, Dehestani B, Holloway KB, Micevych PS, Javaheri A, Crowley JR, Ballabio A, Schilling JD, Epelman S, et al. Exploiting macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis. Nature Communications. 8: 15750. PMID 28589926 DOI: 10.1038/Ncomms15750  0.302
2016 Artyomov MN, Sergushichev A, Schilling JD. Integrating immunometabolism and macrophage diversity. Seminars in Immunology. PMID 27771140 DOI: 10.1016/J.Smim.2016.10.004  0.307
2016 He L, Weber KJ, Diwan A, Schilling JD. Inhibition of mTOR reduces lipotoxic cell death in primary macrophages through an autophagy-independent mechanism. Journal of Leukocyte Biology. PMID 27312848 DOI: 10.1189/Jlb.3A1015-463R  0.323
2016 He L, Weber KJ, Schilling JD. Glutamine Modulates Macrophage Lipotoxicity. Nutrients. 8. PMID 27077881 DOI: 10.3390/Nu8040215  0.314
2014 Weber K, Schilling JD. Distinct lysosome phenotypes influence inflammatory function in peritoneal and bone marrow-derived macrophages. International Journal of Inflammation. 2014: 154936. PMID 25587484 DOI: 10.1155/2014/154936  0.322
2014 Lavine KJ, Epelman S, Uchida K, Weber KJ, Nichols CG, Schilling JD, Ornitz DM, Randolph GJ, Mann DL. Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart. Proceedings of the National Academy of Sciences of the United States of America. 111: 16029-34. PMID 25349429 DOI: 10.1073/Pnas.1406508111  0.328
2014 Epelman S, Lavine KJ, Beaudin AE, Sojka DK, Carrero JA, Calderon B, Brija T, Gautier EL, Ivanov S, Satpathy AT, Schilling JD, Schwendener R, Sergin I, Razani B, Forsberg EC, et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity. 40: 91-104. PMID 24439267 DOI: 10.1016/J.Immuni.2013.11.019  0.308
2013 Schilling JD, Machkovech HM, He L, Diwan A, Schaffer JE. TLR4 activation under lipotoxic conditions leads to synergistic macrophage cell death through a TRIF-dependent pathway. Journal of Immunology (Baltimore, Md. : 1950). 190: 1285-96. PMID 23275600 DOI: 10.4049/Jimmunol.1202208  0.334
2013 Schilling JD, Machkovech HM, He L, Sidhu R, Fujiwara H, Weber K, Ory DS, Schaffer JE. Palmitate and lipopolysaccharide trigger synergistic ceramide production in primary macrophages. The Journal of Biological Chemistry. 288: 2923-32. PMID 23250746 DOI: 10.1074/Jbc.M112.419978  0.33
2012 Lindley KJ, Ravichandran AK, Schilling J, Joseph SM. Antibody-mediated rejection of the heart in the setting of autoimmune demyelinating polyneuropathy: a case report and review of the literature. Case Reports in Cardiology. 2012: 639284. PMID 24826264 DOI: 10.1155/2012/639284  0.302
2012 Schilling JD, Machkovech HM, Kim AH, Schwendener R, Schwedwener R, Schaffer JE. Macrophages modulate cardiac function in lipotoxic cardiomyopathy. American Journal of Physiology. Heart and Circulatory Physiology. 303: H1366-73. PMID 23042950 DOI: 10.1152/Ajpheart.00111.2012  0.32
2011 Schilling J, Lai L, Sambandam N, Dey CE, Leone TC, Kelly DP. Toll-like receptor-mediated inflammatory signaling reprograms cardiac energy metabolism by repressing peroxisome proliferator-activated receptor γ coactivator-1 signaling. Circulation. Heart Failure. 4: 474-82. PMID 21558447 DOI: 10.1161/Circheartfailure.110.959833  0.324
2011 Schilling J, Kelly DP. The PGC-1 cascade as a therapeutic target for heart failure Journal of Molecular and Cellular Cardiology. 51: 578-583. PMID 20888832 DOI: 10.1016/J.Yjmcc.2010.09.021  0.303
2003 Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ. Intracellular bacterial biofilm-like pods in urinary tract infections. Science (New York, N.Y.). 301: 105-7. PMID 12843396 DOI: 10.1126/Science.1084550  0.574
2003 Schilling JD, Martin SM, Hung CS, Lorenz RG, Hultgren SJ. Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America. 100: 4203-8. PMID 12655047 DOI: 10.1073/Pnas.0736473100  0.574
2003 Schilling JD, Martin SM, Hunstad DA, Patel KP, Mulvey MA, Justice SS, Lorenz RG, Hultgren SJ. CD14- and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli. Infection and Immunity. 71: 1470-80. PMID 12595465 DOI: 10.1128/Iai.71.3.1470-1480.2003  0.535
2002 Schilling JD, Hultgren SJ, Lorenz RG. Recent advances in the molecular basis of pathogen recognition and host responses in the urinary tract. International Reviews of Immunology. 21: 291-304. PMID 12486816 DOI: 10.1080/08830180213275  0.603
2002 Schilling JD, Lorenz RG, Hultgren SJ. Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli. Infection and Immunity. 70: 7042-9. PMID 12438384 DOI: 10.1128/Iai.70.12.7042-7049.2002  0.521
2002 Schilling JD, Hultgren SJ. Recent advances into the pathogenesis of recurrent urinary tract infections: the bladder as a reservoir for uropathogenic Escherichia coli. International Journal of Antimicrobial Agents. 19: 457-60. PMID 12135832 DOI: 10.1016/S0924-8579(02)00098-5  0.529
2002 Barnhart MM, Schilling JD, Bäckhed F, Dahlfors AR, Normark S, Hultgren SJ. 7 Host-pathogen interactions: Structure and function of pili Methods in Microbiology. 31: 133-159. DOI: 10.1016/S0580-9517(02)31008-0  0.711
2001 Mulvey MA, Schilling JD, Hultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infection and Immunity. 69: 4572-9. PMID 11402001 DOI: 10.1128/Iai.69.7.4572-4579.2001  0.564
2001 Schilling JD, Mulvey MA, Hultgren SJ. Dynamic interactions between host and pathogen during acute urinary tract infections. Urology. 57: 56-61. PMID 11378051 DOI: 10.1016/S0090-4295(01)01130-X  0.597
2001 Schilling JD, Mulvey MA, Hultgren SJ. Structure and function of Escherichia coli type 1 pili: new insight into the pathogenesis of urinary tract infections. The Journal of Infectious Diseases. 183: S36-40. PMID 11171011 DOI: 10.1086/318855  0.588
2001 Schilling JD, Mulvey MA, Vincent CD, Lorenz RG, Hultgren SJ. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism. Journal of Immunology (Baltimore, Md. : 1950). 166: 1148-55. PMID 11145696 DOI: 10.4049/Jimmunol.166.2.1148  0.571
2000 Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ. Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proceedings of the National Academy of Sciences of the United States of America. 97: 8829-35. PMID 10922042 DOI: 10.1073/Pnas.97.16.8829  0.59
2000 Martinez JJ, Mulvey MA, Schilling JD, Pinkner JS, Hultgren SJ. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. The Embo Journal. 19: 2803-12. PMID 10856226 DOI: 10.1093/Emboj/19.12.2803  0.538
2000 Sauer FG, Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ. Bacterial pili: molecular mechanisms of pathogenesis. Current Opinion in Microbiology. 3: 65-72. PMID 10679419 DOI: 10.1016/S1369-5274(99)00053-3  0.719
Show low-probability matches.